Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 39.4K | $4.72M | $120.05 | Feb 29, 2024 | Direct |
ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 39K | $4.41M | $113.27 | Sep 1, 2024 | Direct |
ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 353 | $41.8K | $118.50 | Feb 29, 2024 | Profit Sharing Trust |
ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 356 | $40.9K | $114.83 | Sep 1, 2024 | Profit Sharing Trust |
ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Option (right to buy) | 86.5K | Feb 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | Sep 1, 2024 | 1 | -$43.8K | 4 | Sep 4, 2024 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 29, 2024 | 1 | -$209K | 4 | Mar 4, 2024 | SENIOR VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 21, 2024 | 2 | $0 | 4 | Feb 23, 2024 | SENIOR VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Sep 1, 2023 | 2 | $0 | 4 | Sep 6, 2023 | SENIOR VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Jun 16, 2023 | 1 | -$848K | 4 | Jun 20, 2023 | VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 28, 2023 | 1 | -$147K | 4 | Mar 2, 2023 | VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 17, 2023 | 2 | $0 | 4 | Feb 22, 2023 | VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 28, 2022 | 1 | -$146K | 4 | Mar 2, 2022 | VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 18, 2022 | 3 | -$113K | 4 | Feb 23, 2022 | VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Oct 25, 2021 | 1 | -$1.01M | 4 | Oct 27, 2021 | VICE PRESIDENT |